SCHEMBL6595017

SCHEMBL6595017

O=C(Nc1ccc(Cl)cn1)c1cc(Cl)cc(O)c1NC(=O)c1scc(CCl)c1Cl

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 16/20 0.66
F2 P00734 19/20 0.65
KLKB1 P03952 2/20 0.65
ELANE P08246 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6589877 0.90 F10 (0.68) F10F2KLKB1ELANE
SCHEMBL6587112 0.88 F10 (0.85) F10F2KLKB1ELANE
SCHEMBL6594350 0.87 F2 (0.65) F10F2KLKB1ELANE
SCHEMBL6596512 0.87 F10 (0.59) F10F2
SCHEMBL6593217 0.87 F10 (0.60) F10F2KLKB1ELANE
SCHEMBL6590864 0.86 F2 (0.82) F10F2KLKB1ELANE
SCHEMBL6591392 0.85 F2 (0.75) F10F2
SCHEMBL6591245 0.85 F2 (0.82) F10F2KLKB1ELANE
SCHEMBL6592461 0.85 F10 (0.71) F10F2KLKB1ELANE
SCHEMBL6593723 0.85 F2 (0.66) F10F2KLKB1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed